. Advantages for both types of treatment have been demonstrated, and great controversy persists with regard to choosing between them for a particular case. In general terms, EC is preferred for aneurysms located in poorly accessible sites, for ruptured aneurysms with severe clinical and neurological conditions and for older patients, with the advantage of prompt postoperative recuperation. The main limitation is aneurysm geometry: cases with a wide neck or large neck/sac ratio, especially if originating in a bifurcation, give rise to complications because of coil protrusion towards the normal vessel. There is also a disconcerting risk of recurrence (about 20%) and need for retreatment (10%) 3 . Balloon remodeling and stent devices minimize these limitations, but make the procedure more risky and expensive. Other features can turn EC into a difficult task, like vessel tortuosity and very small sized sacs. Craniotomy and MC work best for anterior circulation lesions, independently of the neck/sac ratio and location at bifurcations, and for young patients. There are aneurysms with good prognoses from both treatments, and the contrary. Giant, partially thrombosed, wide-necked aneurysms of the posterior circulation are associated with poor results for both techniques. Taking the theme of showing that EC is a good treatment, the article by Abud et al. reports on a series of selected patients who were treated with four different types of EC. They showed that interventional physicians learned to choose the cases in which their techniques would do well. What we cannot know is what proportion of patients presenting to hospital could be treated this way. In the ISAT study, only one quarter of the patients investigated were considered fit for EC and MC concomitantly. Thus, it is reasonable to assume that the patients treated represent only a proportion of those considered for EC. This reveals a limitation of the method, even with its four methods. It is remarkable, however, that "most" of the cases were considered unfit for MC, at least in the judgment of the neurosurgeons at that particular center. In these cases, EC was a treatment that was complementary to MC.
Concurrency created by new therapeutic methods has aided in searching for fragilities within surgical methods and in solving them. Along these lines, the article by Pereira-Filho et al. investigates possible hazards associated with MC, and their concern is admirable. If a hazard exists, knowing about it is the first step towards avoiding it. Perhaps this worry would not appear if there was no competing therapeutic option. Since embolization is carried out without parenchymal manipulation and with a low risk of perforating lesions or ligation, it is believed to be less prone to cause neuropsychological damage, especially in operations involving the anterior communicating region, the carotid bifurcation and the basilar apex 4 . Only a quarter of the aneurysms investigated were located in these regions, and, as mentioned by the authors, other more detailed tests would have shown more subtle alterations. Nevertheless, the intention to search for postoperative abnormalities is positive in itself.
In a case report, Christoph et al. raise the question of choice when both EC and MC are considered feasible. This question is very complex, involving individual judgment, local particularities and patient wishes. Every judgment is subject to error, despite the intention and desire of making the correct choice. When interventional physicians consider that EC is feasible in cases of aneurysm but then discover that it is not feasible, there is still a chance to stop the procedure before a coil has yet been detached. Subsequently, a rescue procedure like stent placement or even surgery may be necessary, thus adding a risk of morbidity. This case also illustrates the need for collaboration between the neurosurgical and intervention teams. However, the risks of over-indication must be remembered and, even though patients' opinions are important, they must come after the technical possibilities have been determined.
In conclusion, the introduction of a new treatment alongside an established one will be marked by controversy, and is a gradual process, taking many years. Nonetheless, this cannot be regarded as anything other than an integral part of progress. The old and new techniques are sometimes complementary and sometimes in competition, but patients are always favored.
